Trucept Is Now Afinida, Inc.

We’re excited to announce that Trucept Inc. is now officially Afinida, Inc. This change aligns our parent company with the unified Afinida brand—bringing together all of our subsidiaries under one name for a stronger, more seamless client experience. Our mission, team, and services remain the same—only now with a name that reflects the future we’re building together.

From Trucept Logo to Afinida Logo

Investors News

Press Releases, Reporting & Filings

Afinida provides businesses with value-added services that drive growth, innovation, and cost containment. Our subsidiaries provide expert services that allow businesses to tap into years of experience in functional areas such as: Human Resources, Payroll, Accounting, Marketing, Risk Management, and Insurance. Regardless of business size, industry, or market share, Afinida clients gain access to proven solutions that tackle their administrative burdens.

Afinida Logo with subsidiaries: Payroll, Risk, Marketing, HR, Accoting, Insurance

afinida’s Stock Chart

Afinida is a Publicly Traded Company.

Latest Press Release

Norman Tipton Returns as Interim CEO to Guide Afinida Through Leadership Transition

Board appoints longtime executive and legal counsel Norman Tipton as interim CEO to provide experienced leadership during the company’s transition. SAN DIEGO, CA – December 1, 2025 – Afinida, Inc. (OTC ID: TREP, “Afinida,” “the Company”)2025 – Norman Tipton,...

Newsletter Signup Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Privacy(Required)

Reporting and Filings

Previous Quarterly Reports

2025 - Quarterly Reports

PUBLISHED
ANNUAL REPORTS
& DISCLOSURES
11/13/2025 SEPTEMBER – QUARTERLY REPORT
08/14/2025 JUNE – QUARTERLY REPORT
05/15/2025 MARCH – QUARTERLY REPORT

2024 - Quarterly Reports

PUBLISHED
ANNUAL REPORTS
& DISCLOSURES
11/19/2024 SEPTEMBER – QUARTERLY REPORT
08/19/2024 JUNE – QUARTERLY REPORT
05/15/2024 MARCH – QUARTERLY REPORT

2023 - Quarterly Reports

PUBLISHED
ANNUAL REPORTS
& DISCLOSURES
11/15/2023 SEPTEMBER – QUARTERLY REPORT
08/21/2023 JUNE – QUARTERLY REPORT
08/14/2023 NOTIFICATION OF LATE FILING
05/15/2023 MARCH – QUARTERLY REPORT

2022 - Quarterly Reports

PUBLISHED
QUARTERLY REPORTS & DISCLOSURES
11/17/2022 SEPTEMBER – OTC DISCLOSURE
11/17/2022 SEPTEMBER QUARTERLY REPORT
11/11/2022 Notification of Late Filing
08/18/2022 JUNE – OTC DISCLOSURE
08/18/2022 JUNE QUARTERLY REPORT
08/15/2022 Notification of Late Filing
05/19/2022 MARCH 2022 – OTC DISCLOSURE
05/19/2022 MARCH QUARTERLY REPORT
05/16/2022 Notification of Late Filing

2021 - Quarterly Reports

PUBLISHED
QUARTERLY REPORTS
& DISCLOSURES
11/16/2021 OTC Disclosure September 30 2021
11/16/2021 September Quarterly Report
11/15/2021 Notification of Late Filing
08/13/2021 June Quarterly Disclosure
08/13/2021 June Quarterly Report
05/21/2021 March Quarterly Disclosure
05/21/2021 March Quarterly Report - Financials and Footnotes
05/17/2021 March Notification of Late Filing

Previous Annual Reports

2024 - Annual Report

PUBLISHED
ANNUAL REPORTS
& DISCLOSURES
03/31/2025 TRUCEPT ANNUAL REPORT 2024

2023 - Annual Reports

PUBLISHED
ANNUAL REPORTS
& DISCLOSURES
03/25/2024 TRUCEPT ANNUAL REPORT 2023

2022 - Annual Reports

PUBLISHED
ANNUAL REPORTS
& DISCLOSURES
03/27/2023 ANNUAL REPORT - TRUCEPT ANNUAL DISCLOSURE 2022
03/27/2023 TRUCEPT ANNUAL REPORT 2022

2020 - Annual Reports

PUBLISHED
ANNUAL REPORTS
& DISCLOSURES
04/05/2021 Attorney Letter with Respect to Current Information - Revised
03/31/2021 Annual Report - Annual Disclosure
03/31/2021 Annual Report - December 31st 2020

Consolidated Financial Statements

More Press Releases

Afinida Reports Q3 2025 Revenue, Expands Subsidiary Growth

Afinida Reports Q3 2025 Revenue, Expands Subsidiary Growth

Parent company continues to strengthen diversified service offerings while positioning for sustainable long-term growth SAN DIEGO, CA – ACCESS Newswire – November 19, 2025 – Afinida, Inc. (OTC ID: TREP, “Afinida,” “the Company”), today announced its financial results for the quarter ending September 30, 2025. The Company reported $16.9 million in year-to-date revenue, supported by its expanding portfolio of business service...

read more

afinida Stock Chart Enhanced